August 28, 2023 Sophia Vida
Breaking News

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

First digital-droplet PCR assay to receive coverage Expect initial revenue generation in Q1 2024 IRVINE, CA, August 28, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that Palmetto GBA, the Medicare Administrative Contractor for the Centers for Medicare & Medicaid Services (CMS), has issued a positive coverage decision for the Company’s VitaGraft … Continue reading “Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage”